Risk factors for death including initial admission to COVID-19 quarantine before isolation vs. direct admission to isolation at King Edward VIII hospital in South Africa: A case-control study 10.55131/jphd/2025/230320
Main Article Content
Abstract
Worldwide, the emergence of the novel coronavirus disease 2019 (COVID-19) has resulted in millions of deaths. This study aims to investigate the relationship between death during admission and various risk factors thereof including admission to COVID-19 quarantine before isolation vs. direct admission to isolation, among COVID-19 patients at King Edward VIII Hospital. A case-control study design was employed, involving 400 COVID-19 patients (200 cases and 200 controls by a 1:1 ratio). Patient information was retrospectively abstracted from medical records. Associations between risk factors and mortality were assessed using chi-square tests, followed by univariate and multivariate logistic regression analyses. Among the 200 cases, 133 were referred from primary or secondary levels of care, compared to 71 out of 200 controls. The mean age of patients was 55.6 years (SD: 16.2 years), and 177 (44.2%) patients were male. Out of the total number of patients, 181 (45.2%) patients were initially admitted to the COVID-19 quarantine ward before isolation, while 219 (54.7%) patients were directly admitted to the COVID-19 isolation ward. Increasing age (adjusted odds ratio [aOR]:˃ 60 years: 6.49 [95%CI: 2.97-14.16]), admission directly to isolation ([aOR]: 2.49[95%CI:1.53-4.06]), Fever ([aOR]: 1.74[95%CI:1.03-2.91]) Shortness of breath ([aOR]: 4.86[95%CI:2.53-9.35]), CKD (Chronic Kidney Disease) ([aOR]: 10.39 [95%CI:2.09-51.61]), and obesity ([aOR]: 4.85[95%CI:1.88-12.46]) were associated with death among COVID-19 patients during admission on multivariate analysis. Understanding and addressing these factors can help healthcare systems develop targeted strategies to improve patient outcomes and reduce mortality rates.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
World Health Organization. Coronavirus disease (COVID-19) pandemic. 2020. Available from: https://covid19.who.int/
Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395(10239):1763-70.
Worldometer. COVID-19 Coronavirus pandemic. Available from: https:// www.worldometers.info/coronavirus/ Accessed 07 July 2023, 10:30 AM.
Alimohamadi Y, Taghdir M, Sepandi M. The estimate of the basic reproduction number for novel coronavirus disease (COVID-19): a systematic review and meta-analysis. J Prev Med Public Health. 2020;53:151–7. doi: 10.3961/jpmph.20.076.
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission, and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Mil Med Res. 2020;7:11. doi: 10.1186/ s40779-020-00240-0.
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of 72314 cases reported from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–42. doi: 10.1001/jama.2020.2648.
Tartof SY, Qian L, Hong V, Wei R, Nadjafi RF, Fischer H, et al. Obesity and mortality among patients diagnosed with COVID-19: results from an Integrated Health Care Organization. Ann Intern Med. 2020;173:773–81. doi: 10.7326/M20-3742.
African C. Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): multicenter, prospective, observational cohort study. Lancet. 2021;397:1885–94. doi: 10.1016/S0140-6736(21) 00441-4.
Manimani RG, Willy TM, Nombulelo M. Risk factors for death in hospitalized COVID-19 patients in Africa: a systematic review and meta-analysis. Medicine. 2023. doi: 10.1097/MD. 0000000000034405.
Claassen N, van Wyk G, van Staden S, Basson MM. Experiencing COVID-19 at a large district level hospital in Cape Town: A retrospective analysis of the first wave. South African J Infect Dis. 2022;37.
Beaudry G, Zhong S, Whiting D, Javid B, Frater J, Fazel S. Managing outbreaks of highly contagious diseases in prisons: a systematic review. BMJ Glob Health. 2020;5(11)
Krishnan A, Kumar R, Amarchand R, Mohan A, Kant R, Agarwal A, et al. Predictors of Mortality among Patients Hospitalized with COVID-19 during the First Wave in India: A Multisite Case-Control Study. Am J Trop Med Hyg. 2023;108(4):727.
Animut Z, Bedimo M, Bitew A, Fenta S, Menegist A. Determinants of Death among COVID-19 Patients Admitted in Amhara Region COVID-19 Treatment Centers, Ethiopia, 2021, Unmatched Case Control Study. J Infect Dis Epidemiol. 2022;8:252.
Bepouka BI, Mandina M, Makulo JR, Longokolo M, Odio O, Mayasi N, et al. Predictors of mortality in COVID-19 patients at Kinshasa University Hospital, Democratic Republic of the Congo from March to June 2020. Pan Afr Med J. 2020;37(1).
Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections?. Front Physiol. 2021;11:571416.
Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021;21(1):1-28.
Pawelec G. Age and immunity: what is “immunosenescence”?. Exp Gerontol. 2018;105:4-9.
Chen Y, Klein SL, Garibaldi BT, Li H, Wu C, Osevala NM, et al. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res Rev. 2021;65:101205.
Fung SY, Yuen KS, Ye ZW, Chan CP, Jin DY. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerg Microbes Infect. 2020;9(1):558-70.
Klein SL, Pekosz A, Park HS, Ursin RL, Shapiro JR, Benner SE, et al. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. J Clin Invest. 2020;130(11):6141-50.
Zhang B, Zhou X, Zhu C, Song Y, Feng F, Qiu Y, et al. Immune phenotyping based on the neutrophil-to-lymphocyte ratio and IgG level predicts disease severity and outcome for patients with COVID-19. Front Mol Biosci. 2020; 7:157.
Nasiri MJ, Haddadi S, Tahvildari A, Farsi Y, Arbabi M, Hasanzadeh S, et al. COVID-19 clinical characteristics, and sex-specific risk of mortality: systematic review and meta-analysis. Front Med. 2020;7:459.
Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, et al. Predictors of mortality in hospitalized COVID‐19 patients: a systematic review and meta‐analysis. J Med Virol. 2020;92(10): 1875-83.
Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis. 2005;41(Supplement_7)
Sousa GJ, Garces TS, Cestari VR, Florêncio RS, Moreira TM, Pereira ML. Mortality and survival of COVID-19. Epidemiol Infect. 2020;148.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.
Abebe HT, Mulugeta A, Berhe Y, Berhane K, Siraj A, Siraj D, et al. Risk factors for mortality among hospitalized COVID-19 patients in Northern Ethiopia: A retrospective analysis. PLoS One. 2022;17(8).
Bepouka BI, Mandina M, Makulo JR, Longokolo M, Odio O, Mayasi N, et al. Predictors of mortality in COVID-19 patients at Kinshasa University Hospital, Democratic Republic of the Congo, from March to June 2020. Pan Afr Med J. 2020;37.
Animut Z, Bedimo M, Bitew A, Fenta S, Menegist A. Determinants of Death among COVID-19 Patients Admitted in Amhara Region COVID-19 Treatment Centers, Ethiopia, 2021, Unmatched Case Control Study. J Infect Dis Epidemiol. 2022;8:252.
Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, et al. Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence. Circulation. 2020;142(2):184-6.
Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020 Jun 6;395(10239):1763-70.
Dorjee K, Kim H, Bonomo E, Dolma R. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients. PLoS One. 2020 Dec 7;15(12)
Shi C, Wang L, Ye J, Gu Z, Wang S, Xia J, et al. Predictors of mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis. BMC Infect Dis. 2021 Dec;21(1):1-5.
Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021 Dec;21(1):1-28.
Mehraeen E, Karimi A, Barzegary A, Vahedi F, Afsahi AM, Dadras O, et al. Predictors of mortality in patients with COVID-19–a systematic review. Eur J Integr Med. 2020 Dec 1;40:101226.
Cai R, Zhang J, Zhu Y, Liu L, Liu Y, He Q. Mortality in chronic kidney disease patients with COVID-19: a systematic review and meta-analysis. Int Urol Nephrol. 2021 Aug;53(8): 1623-9.
Betjes MG. Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol. 2013 May; 9(5):255-65.
Petrakis D, Margină D, Tsarouhas K, Tekos F, Stan M, Nikitovic D, et al. Obesity a risk factor for increased COVID 19 prevalence, severity and lethality. Mol Med Rep. 2020 Jul 1;22(1):9-19.
Goumenou M, Sarigiannis D, Tsatsakis A, Anesti O, Docea AO, Petrakis D, et al. COVID 19 in Northern Italy: An integrative overview of factors possibly influencing the sharp increase of the outbreak. Mol Med Rep. 2020 Jul 1;22(1):20-32.
Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021 Aug 21;21(1):855.
Poutahidis T, Kleinewietfeld M, Smillie C, Levkovich T, Perrotta A, Bhela S, et al. Microbial reprogramming inhibits Western diet associated obesity. PLoS One. 2013;8
Winer S, Paltser G, Chan Y, Tsui H, Engleman E, Winer D, Dosch HM. Obesity predisposes to Th17 bias. Eur J Immunol. 2009;39:2629-35.
Skalny AV, Rink L, Ajsuvakova OP, Aschner M, Gritsenko VA, Alekseenko SI, et al. Zinc and respiratory tract infections: perspectives for COVID-19 (Review). Int J Mol Med. 2020.
Sumarac-Dumanovic M, Stevanovic D, Ljubic A, Jorga J, Simic M, Stamenkovic-Pejkovic D, et al. Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes. 2009 Jan;33(1):151-6.
Jain S, Chaves SS. Obesity and influenza. Clin Infect Dis. 2011 Sep 1;53(5):422-4.
Price MN, Dehal PS, Arkin AP. FastTree 2–approximately maximum-likelihood trees for large alignments. PLoS One. 2010 Mar 10;5(3)
Louie JK, Acosta M, Samuel MC, Schechter R, Vugia DJ, Harriman K, et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis. 2011 Feb 1;52(3):301-12.
Betjes MG. Uremia-associated ageing of the thymus and adaptive immune responses. Toxins (Basel). 2020 Apr 3;12(4):224.
Imig JD, Ryan MJ. Immune and inflammatory role in renal disease. Compr Physiol. 2013 Apr;3(2):957.
Lely AT, Hamming I, van Goor H, et al. Renal ACE2 expression in human kidney disease. J Pathol. 2004 Dec;204(5):587–93.
Fan C, Li K, Ding Y, Lu WL, Wang J. ACE2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection. medRxiv. 2020.
Li X, Zhong X, Wang Y, Zeng X, Luo T, Liu Q. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis. PLoS One. 2021 May 3;16(5)
Sattar N, McInnes IB, McMurray JJ. Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation. 2020 Jul 7;142(1):4-6.
Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci. 2019 May 13;20(9):2358.
Britton KA, Fox CS. Ectopic fat depots and cardiovascular disease. Circulation. 2011 Dec 13;124(24)
Bastien M, Poirier P, Lemieux I, et al. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014;56:369-81.
Ni YN, Yu H, Xu H, Li WJ, Liang BM, Yang L, et al. High visceral adipose tissue to subcutaneous adipose tissue ratio as a predictor of mortality in acute respiratory distress syndrome. Am J Med Sci. 2019 Mar;357(3):213-22.
Krishnan A, Kumar R, Amarchand R, Mohan A, Kant R, Agarwal A, et al. Predictors of mortality among patients hospitalized with COVID-19 during the first wave in India: a multisite case-control study. Am J Trop Med Hyg. 2023 Apr;108(4):727.
Mehraeen E, Karimi A, Barzegary A, Vahedi F, Afsahi AM, Dadras O, et al. Predictors of mortality in patients with COVID-19–a systematic review. Eur J Integr Med. 2020 Dec 1;40:101226.